PARIS, IL —
An insulin pump “should certainly be an alternative” to multiple daily injections for selected Type 1 diabetic patients in clinical practice, according to Debbie Griffin, a family nurse practitioner at Paris Community Hospital/Family Medical Center.
Her findings were published in the September/October 2012 edition of Practical Diabetology, a national medical journal. Griffin, who is also an American Diabetes Association diabetes educator, co-authored the article titled, “Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections.” Other contributing authors were Cherie Howk, Ph.D., family nurse practitioner and adjunct professor at Indiana State University, and Eugenia Caternor, family nurse practitioner from Baltimore, Md.
The published article concludes that continuous subcutaneous insulin infusion – commonly known as an insulin pump – better controls blood sugar than multiple daily injections without increasing the risk of hypoglycemia (low blood sugar). The article also notes the following:
• Type 1 diabetic patients treated with insulin pumps show a greater reduction in HbA1C (their average blood sugar level measured over the previous three months).
• Patients using insulin pumps have fewer hypoglycemia events.
• An insulin pump is a viable option for patients who want more flexibility in their lifestyle, including meal times.
• The number of insulin pump users in the U.S. has grown from 70,000 to more than 300,000 since 1998, largely because of technological advances.
Griffin is a member of the American Diabetes Association, the American Association of Diabetes Educators and the Edgar County Diabetes Association. She earned her bachelor’s degree and master’s degree in nursing from Indiana State University.